RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Proto Script Pharmaceutical Stock

Proto Script Pharmaceutical P/S 2024

Proto Script Pharmaceutical P/S

0

Ticker

PSCR

ISIN

US74373V1052

As of Sep 30, 2024, Proto Script Pharmaceutical's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Proto Script Pharmaceutical P/S history

Proto Script Pharmaceutical Aktienanalyse

What does Proto Script Pharmaceutical do?

Proto Script Pharmaceutical Corp is an American biotechnology company specializing in the development and manufacture of innovative, high-quality drugs. The company is focused on researching new breakthrough technologies in drug manufacturing to find potential cures and treat diseases. Their business model is based on producing medications that are highly effective and of high quality while also being cost-effective and patient-friendly. They collaborate closely with biotechnology companies and academic institutions to acquire the best technologies and develop effective and innovative drugs. They have products in the areas of neurology, endocrine health, and oncology. They have also entered into partnerships with other companies to expand and further develop their products. Overall, Proto Script Pharmaceutical Corp is a groundbreaking company in the biotechnology field with decades of experience in drug development and a commitment to improving the lives of millions of people worldwide. Proto Script Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Proto Script Pharmaceutical's P/S Ratio

Proto Script Pharmaceutical's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Proto Script Pharmaceutical's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Proto Script Pharmaceutical's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Proto Script Pharmaceutical’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Proto Script Pharmaceutical stock

What is the price-to-earnings ratio of Proto Script Pharmaceutical?

The price-earnings ratio of Proto Script Pharmaceutical is currently 0.

How has the price-earnings ratio of Proto Script Pharmaceutical changed compared to last year?

The price-to-earnings ratio of Proto Script Pharmaceutical has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Proto Script Pharmaceutical high compared to other companies?

Yes, the price-to-earnings ratio of Proto Script Pharmaceutical is high compared to other companies.

How does an increase in the price-earnings ratio of Proto Script Pharmaceutical affect the company?

An increase in the price-earnings ratio of Proto Script Pharmaceutical would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Proto Script Pharmaceutical affect the company?

A decrease in the price-earnings ratio of Proto Script Pharmaceutical would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Proto Script Pharmaceutical?

Some factors that influence the price-earnings ratio of Proto Script Pharmaceutical are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Proto Script Pharmaceutical pay?

Over the past 12 months, Proto Script Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Proto Script Pharmaceutical is expected to pay a dividend of 0 USD.

What is the dividend yield of Proto Script Pharmaceutical?

The current dividend yield of Proto Script Pharmaceutical is .

When does Proto Script Pharmaceutical pay dividends?

Proto Script Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Proto Script Pharmaceutical?

Proto Script Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Proto Script Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Proto Script Pharmaceutical located?

Proto Script Pharmaceutical is assigned to the '-' sector.

Wann musste ich die Aktien von Proto Script Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Proto Script Pharmaceutical from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Proto Script Pharmaceutical pay the last dividend?

The last dividend was paid out on 9/30/2024.

What was the dividend of Proto Script Pharmaceutical in the year 2023?

In the year 2023, Proto Script Pharmaceutical distributed 0 USD as dividends.

In which currency does Proto Script Pharmaceutical pay out the dividend?

The dividends of Proto Script Pharmaceutical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Proto Script Pharmaceutical

Our stock analysis for Proto Script Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Proto Script Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.